SecBot SecBot
8-K ·Filed May 15, 2026

SKYE

Skye Bioscience, Inc.
BEARISH
Impact 7/10
Horizonweeks Processed6mo ago SEC0001628280-26-035535
8-K context-dependent: Items 3.01
Actionable Insight ▼ Bearish

Monitor for the company's compliance plan submission by June 29, 2026. A capital raise (equity or debt) is the most likely cure, which would be dilutive. Failure to regain compliance could lead to delisting, a severe liquidity event. The stock may face selling pressure as institutional holders reduce positions due to listing risk.

DirectionBearish
Confidencehigh
Horizonweeks

How the stock moved after the report

BEARISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$0.7780
T+0 close · May 15, 2026 · via day close
Latest settled
−29.45%
T+60 · $0.5489
Vs SPY
−34.30%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 18 $0.7780entry
  2. T+1 · 6mo ago −6.81%α −6.16% · $0.7250
  3. T+5 · 6mo ago +5.66%α +4.04% · $0.8220
  4. T+20 · 5mo ago −7.66%α −9.24% · $0.7184
  5. T+60 · 3mo ago −29.45%α −34.30% · $0.5489
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Skye Bioscience received a Nasdaq delisting notice on May 13, 2026, for failing to meet the $10M minimum stockholders' equity requirement (reported equity: $9,011,804). The company has 45 days to submit a compliance plan, with a possible 180-day extension to cure. Failure to regain compliance could result in delisting from the Nasdaq Global Market, severely impacting liquidity and institutional ownership.

Key Facts

  • Stockholders' equity was $9,011,804 as of March 31, 2026, below the $10,000,000 minimum required by Nasdaq Listing Rule 5450(b)(1)(A).
  • Company has until June 29, 2026 to submit a compliance plan to Nasdaq.
  • If plan is accepted, Nasdaq may grant an extension until November 9, 2026 to regain compliance.
  • No immediate effect on trading; stock continues to trade under symbol SKYE.
  • Company is evaluating alternatives but provides no assurance of regaining compliance.

Financial Impact

Stockholders' equity shortfall of approximately $988,196 against the $10M minimum requirement.

stockholdersEquity

Risk Factors

  • Delisting from Nasdaq if compliance plan is rejected or not executed within the extension period.
  • Potential dilutive capital raise to boost equity above $10M.
  • Loss of institutional investor base and liquidity upon delisting.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
79% bullish (14 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001628280-26-035535
Document: 0001628280-26-035535-index-headers.html0001628280-26-035535
Document: 0001628280-26-035535-index.html0001628280-26-035535
Document: 0001628280-26-035535.txt0001628280-26-035535

Track record

16 reports on SKYE

Performance horizon

4 of 4 bullish or bearish reports moved the stock their way by T+20. Best: +82.80% at T+60 after the Aug 14, 2026 report. 5 of 5 went positive at some point.

Filters
  1. Nov 12, 20264d ago DEFA14A Neutral 3/10 Entry $1.08 Now $1.07 −1.39% settles Dec 11
  2. Nov 12, 20264d ago 8-K Neutral 3/10 Entry $1.08 Now $1.07 −1.39% settles Dec 11
  3. Oct 26, 202621d ago PREM14A Bearish 7/10 Entry $1.45 Now $1.07 +26.55% settles Nov 24
  4. Oct 14, 20264w ago SC 13G Neutral 4/10 Entry $1.59 to $1.08 Now $1.07 −33.02% ▼ −32.08% −30.17% vs SPY
  5. Sep 24, 20267w ago Insider Cluster Neutral 3/10 Entry $1.67 to $1.54 Now $1.07 −36.23% ▼ −7.78% −6.31% vs SPY
  6. Sep 24, 20267w ago SC 13D/A Bearish 6/10 Entry $1.67 to $1.54 Now $1.07 +36.23% ▲ +7.78% +6.31% vs SPY
  7. Sep 18, 20268w ago Insider Cluster Bearish 4/10 Entry $1.78 to $1.53 Now $1.07 +40.17% ▲ +14.04% +13.14% vs SPY
  8. Aug 19, 202612w ago DEFA14A Neutral 4/10 Entry $0.2809 to $0.2206 Now $1.07 +279.14% ▼ −21.46% −21.34% vs SPY
  9. Aug 14, 202613w ago 8-K Mixed 7/10 Entry $0.5015 to $0.2487 Now $1.07 +112.36% ▼ −50.40% −48.41% vs SPY
  10. Aug 14, 202613w ago Press Release Bearish 7/10 Entry $0.5015 to $0.2487 Now $1.07 −112.36% ▲ +50.40% +48.41% vs SPY
Showing 10 of 16

US Market Status

Market Closed · Opens in 6h 40m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 15, 2026